MHPSY yields 25.01% · PFE yields 6.13%● Live data
📍 PFE pulled ahead of the other in Year 9
Combined, MHPSY + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of MHPSY + PFE for your $10,000?
MHP SE, together with its subsidiaries, produces and sells food and poultry products in Ukraine and internationally. It operates in four segments: Poultry & Related Operations, Grain Growing Operations, Meat-Processing & Other Agricultural Operations, and European Operating. The Poultry & Related Operations segment produces and sells fresh and frozen chicken meats, vegetable oils, including sunflower and soybean, as well as mixed fodder under the brand Nasha Riaba, Apetytna, Baschinsky, Vinnytski Kurchata, Kurator, Sultanah, Assilah, Al-Hassanat, Home Style Chicken, Ukrainian Chicken, and Chef's Secrets names to export markets. The company's Grain Growing Operations segment grows crops for fodder production and sale to third parties. Its Meat-Processing & Other Agricultural Operations segment produces and sells sausages, processed and cooked meats, convenience foods, and produce from cattle and diary operations under the Bashchinsky, Lehko!,Qualiko, Skott Smeat, and Sytni brands. The European Operating segment engages in the production and sale of chicken meat and processed poultry meat products under the PP and Poli brands. It is also involved in hatching eggs; and growing of corn, sunflower, and soybean seeds, as well as rape and wheat grains to third parties. MHP SE was founded in 1998 and is headquartered in Kiev, Ukraine.
Full MHPSY Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.